These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 17335811

  • 1. The selective kappa-opioid receptor agonist U50,488 reduces L-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates.
    Cox H, Togasaki DM, Chen L, Langston JW, Di Monte DA, Quik M.
    Exp Neurol; 2007 May; 205(1):101-7. PubMed ID: 17335811
    [Abstract] [Full Text] [Related]

  • 2. Enhanced striatal opioid receptor-mediated G-protein activation in L-DOPA-treated dyskinetic monkeys.
    Chen L, Togasaki DM, Langston JW, Di Monte DA, Quik M.
    Neuroscience; 2005 May; 132(2):409-20. PubMed ID: 15802193
    [Abstract] [Full Text] [Related]

  • 3. Effect of acute and chronic administration of U50,488, a kappa opioid receptor agonist, in 6-OHDA-lesioned rats chronically treated with levodopa.
    Marin C, Bové J, Bonastre M, Tolosa E.
    Exp Neurol; 2003 Sep; 183(1):66-73. PubMed ID: 12957489
    [Abstract] [Full Text] [Related]

  • 4. Brain 5-HT(2A) receptors in MPTP monkeys and levodopa-induced dyskinesias.
    Riahi G, Morissette M, Parent M, Di Paolo T.
    Eur J Neurosci; 2011 May; 33(10):1823-31. PubMed ID: 21501255
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The α7 nicotinic receptor agonist ABT-107 decreases L-Dopa-induced dyskinesias in parkinsonian monkeys.
    Zhang D, McGregor M, Decker MW, Quik M.
    J Pharmacol Exp Ther; 2014 Oct; 351(1):25-32. PubMed ID: 25034405
    [Abstract] [Full Text] [Related]

  • 7. Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on L-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeys.
    Hsu A, Togasaki DM, Bezard E, Sokoloff P, Langston JW, Di Monte DA, Quik M.
    J Pharmacol Exp Ther; 2004 Nov; 311(2):770-7. PubMed ID: 15226382
    [Abstract] [Full Text] [Related]

  • 8. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
    Jourdain VA, Morin N, Grégoire L, Morissette M, Di Paolo T.
    J Neurosurg; 2015 Dec; 123(6):1383-93. PubMed ID: 25932606
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nicotine-mediated improvement in L-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function.
    Quik M, Mallela A, Chin M, McIntosh JM, Perez XA, Bordia T.
    Neurobiol Dis; 2013 Feb; 50():30-41. PubMed ID: 23009753
    [Abstract] [Full Text] [Related]

  • 11. α7 nicotinic receptor agonists reduce levodopa-induced dyskinesias with severe nigrostriatal damage.
    Zhang D, McGregor M, Bordia T, Perez XA, McIntosh JM, Decker MW, Quik M.
    Mov Disord; 2015 Dec; 30(14):1901-1911. PubMed ID: 26573698
    [Abstract] [Full Text] [Related]

  • 12. Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus).
    Pearce RK, Jackson M, Smith L, Jenner P, Marsden CD.
    Mov Disord; 1995 Nov; 10(6):731-40. PubMed ID: 8749992
    [Abstract] [Full Text] [Related]

  • 13. 7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate.
    Herrero MT, Yuste JE, Cuenca-Bermejo L, Almela P, Arenas-Betancur L, De Pablos V, Gonzalez-Cuello A, Del Bel E, Navarro-Zaragoza J, Fernández-Villalba E.
    Open Biol; 2023 May; 13(5):220370. PubMed ID: 37192671
    [Abstract] [Full Text] [Related]

  • 14. Increases in striatal preproenkephalin gene expression are associated with nigrostriatal damage but not L-DOPA-induced dyskinesias in the squirrel monkey.
    Quik M, Police S, Langston JW, Di Monte DA.
    Neuroscience; 2002 May; 113(1):213-20. PubMed ID: 12123699
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Henry B, Crossman AR, Brotchie JM.
    Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides.
    Tamim MK, Samadi P, Morissette M, Grégoire L, Ouattara B, Lévesque D, Rouillard C, Di Paolo T.
    Neuropharmacology; 2010 Jan; 58(1):286-96. PubMed ID: 19576910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.